§ 21-28-3.03. Registration.
(a) The director of health shall register an applicant to manufacture, distribute, prescribe, administer, or dispense controlled substances unless he or she determines that the issuance of that registration would be inconsistent with the public interest. In determining the public interest, the director of health may consider, but shall not be limited to, the following factors:
(1) Maintenance of effective controls against diversion of controlled substances into other than legitimate medical, scientific, or industrial channels;
(2) Compliance with applicable federal, state, and local law;
(3) Conviction of a crime or plea of nolo contendere by the applicant of any state or federal law involving the sale of, trafficking in, or abuse of a controlled substance;
(4) Past experience in the manufacture, distribution, prescribing, administration, or dispensing of controlled substances, and the existence in the applicant’s establishment of effective controls against diversion;
(5) Furnishing by the applicant of false or fraudulent material in any application filed under this chapter;
(6) Suspension or revocation of the applicant’s federal registration to manufacture, distribute, prescribe, administer, or dispense controlled substances as authorized by federal law.
(b) Registration under subsection (a) of this section does not entitle a registrant to manufacture and distribute controlled substances in schedule I or II other than those specified in his or her registration.
(c) Practitioners must be registered in accordance with subsection (a) of this section to prescribe, administer, and dispense any controlled substance or to conduct research with controlled substances in schedules II through V. The director of health need not require separate registration under this section for practitioners engaging in research with non-narcotic controlled substances in schedules II through V where the registrant is already registered under this chapter in another capacity. Practitioners registered under federal law to conduct research with schedule I substances may conduct research with schedule I substances within this state upon furnishing the director of health evidence of that federal registration.
(d) Compliance by manufacturers and distributors with the provisions of the federal law respecting registration (excluding fees) entitles them to be registered under this chapter.
History of Section.P.L. 1974, ch. 183, § 2; P.L. 1980, ch. 257, § 1.
Structure Rhode Island General Laws
Chapter 21-28 - Uniform Controlled Substances Act
Section 21-28-3.01. - Rules and regulations — Fees.
Section 21-28-3.02. - Registration requirements.
Section 21-28-3.03. - Registration.
Section 21-28-3.04. - Suspension or revocation of registration.
Section 21-28-3.05. - Order to show cause.
Section 21-28-3.06. - License required for manufacture.
Section 21-28-3.07. - Qualifications for licensees.
Section 21-28-3.08. - Disposition of license fees.
Section 21-28-3.09. - Denial, revocation, or suspension of licenses.
Section 21-28-3.10. - Authorized sales by manufacturers and wholesalers on official written orders.
Section 21-28-3.11. - Form, delivery, and preservation of official written orders.
Section 21-28-3.12. - Records of controlled substances used in professional practice.
Section 21-28-3.13. - Records of manufacturers and wholesalers.
Section 21-28-3.14. - Records of apothecaries.
Section 21-28-3.15. - Records of vendors of schedule V substances.
Section 21-28-3.16. - Form, content, and preservation of records.
Section 21-28-3.17. - Records open to inspection.
Section 21-28-3.18. - Prescriptions.
Section 21-28-3.19. - Sale of stock on discontinuance of pharmacy business.
Section 21-28-3.20. - Authority of practitioner to prescribe, administer, and dispense.
Section 21-28-3.21. - Operation of treatment and rehabilitation programs for drug dependent persons.
Section 21-28-3.22. - Administration, dispensation or use restricted to scope of employment or duty.
Section 21-28-3.23. - Advertising controlled substances.
Section 21-28-3.24. - Examination before use of controlled substances.
Section 21-28-3.25. - Subpoena powers.
Section 21-28-3.26. - Labeling by manufacturers and wholesalers.
Section 21-28-3.27. - Labeling by dispensing apothecaries.
Section 21-28-3.28. - Security requirements generally.
Section 21-28-3.29. - Repealed.
Section 21-28-3.30. - Persons exempt from restrictions on possession of controlled substances.
Section 21-28-3.31. - Use of imitation controlled substance in research — Immunity.
Section 21-28-3.32. - Electronic prescription database. [Effective until January 1, 2023.]